Completed PHASE2 INTERVENTIONAL 5-arm NCT01325350

Safety and Efficacy Study of Bimatoprost in the Treatment of Women With Female Pattern Hair Loss

Sponsor: Allergan

Interventions bimatoprost Formulation A bimatoprost Formulation B bimatoprost Formulation C bimatoprost vehicle solution minoxidil 2% solution

Updated 6 times since 2017 Last updated: Mar 3, 2014 Started: Jun 30, 2011 Primary completion: Jul 31, 2012 Completion: Sep 30, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Alopecia and Baldness, this trial is completed. The trial is conducted by Allergan and has accumulated 6 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Jun 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Allergan

Data source: Allergan

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Berlin, Germany
• Portland, United States